PeƱalosa, Jovelyn U.
HRN: 18-51-03 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/18/2026
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
02/18/2026
02/25/2026
IV
4.5 G
Every 6 Hours
S/P CS With Hysterectomy
Pending Pharmacy Acceptance
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: